IMD Companies Inc (ICBU)
0.0004
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
IMD 1 Year Total Returns (Daily): -25.00% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -25.00% |
May 02, 2024 | 0.00% |
May 01, 2024 | -10.00% |
April 30, 2024 | -16.67% |
April 29, 2024 | -16.67% |
April 26, 2024 | 0.00% |
April 25, 2024 | -8.33% |
April 24, 2024 | -16.67% |
April 23, 2024 | -16.67% |
April 22, 2024 | -16.67% |
April 19, 2024 | -21.43% |
April 18, 2024 | 0.00% |
April 17, 2024 | -16.67% |
April 16, 2024 | -16.67% |
April 15, 2024 | -33.33% |
April 12, 2024 | -38.46% |
April 11, 2024 | -8.33% |
April 10, 2024 | -21.88% |
April 09, 2024 | -15.38% |
April 08, 2024 | -15.38% |
April 05, 2024 | -15.38% |
April 04, 2024 | -22.86% |
April 03, 2024 | -46.67% |
April 02, 2024 | -46.67% |
April 01, 2024 | -40.00% |
Date | Value |
---|---|
March 28, 2024 | -40.00% |
March 27, 2024 | -42.86% |
March 26, 2024 | -28.57% |
March 25, 2024 | -35.71% |
March 22, 2024 | -50.00% |
March 21, 2024 | -50.00% |
March 20, 2024 | -47.06% |
March 19, 2024 | -50.00% |
March 18, 2024 | -50.00% |
March 15, 2024 | -55.00% |
March 14, 2024 | -50.00% |
March 13, 2024 | -44.44% |
March 12, 2024 | -47.06% |
March 11, 2024 | -47.06% |
March 08, 2024 | -50.00% |
March 07, 2024 | -55.56% |
March 06, 2024 | -55.56% |
March 05, 2024 | -38.89% |
March 04, 2024 | -44.44% |
March 01, 2024 | -46.67% |
February 29, 2024 | -60.00% |
February 28, 2024 | -56.00% |
February 27, 2024 | -60.00% |
February 26, 2024 | -55.56% |
February 23, 2024 | -57.14% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.93%
Minimum
Mar 21 2022
11.70K%
Maximum
Mar 23 2021
440.9%
Average
-26.67%
Median
Jul 20 2023
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -15.65% |
Perspective Therapeutics Inc | 196.0% |
Protalix BioTherapeutics Inc | -63.81% |
Electromed Inc | 78.40% |
Armata Pharmaceuticals Inc | 61.69% |